Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
INTELLIGENT BIO SOLUTIONS INC.
Intelligent Bio Solutions Inc. will hold its annual meeting on December 3, 2026, to vote on director elections, auditor ratification, amendments to the 2019 Long Term Incentive Plan, and the issuance of up to 2,036,659 shares of common stock upon the exercise of Series N-2 Warrants issued on September 2, 2026. The meeting seeks shareholder approval to comply with Nasdaq Listing Rule 5635(d), with voting rights granted to shareholders of record as of October 13, 2026.…more
INTELLIGENT BIO SOLUTIONS INC.
Intelligent Bio Solutions Inc. filed an amendment (Form 10-K/A) to its 2026 Annual Report to revise executive compensation disclosures, clarify capital raising transactions involving major shareholders, and update the exhibit index. There are no changes to the financial statements, and the company reported 3,027,470 shares of common stock issued and outstanding as of August 18, 2026.…more
INTELLIGENT BIO SOLUTIONS INC.
Intelligent Bio Solutions Inc. amended its Bylaws on October 12, 2026, to revise the voting procedures for stockholder meetings. The amendment clarifies that matters other than the election of directors will be decided by a majority of the votes cast, explicitly excluding abstentions and broker non-votes.…more
19 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Intelligent Bio Solutions Registers 6.2M Shares for Warrant Exercise
Intelligent Bio Solutions has registered over 6.2 million shares of common stock for resale, which are issuable upon the exercise of warrants from a private placement. This registration indicates potential share dilution, which may negatively impact the stock price.…more
●●●●●●●● ●●●●● ●●●●●●
Intelligent Bio Solutions will host a virtual fireside chat to discuss its FDA 510(k) submission, clinical data, and international commercial progress. Management will provide updates on the regulatory process and the company's business outlook during the live session.…more
●●●●●●●● ●●●●● ●●●●●●
Intelligent Bio Solutions has submitted a 510(k) premarket notification to the FDA for its fingerprint-based drug screening system. This filing leverages extensive clinical data as the company aims to expand its commercial presence in the U.S. market.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.